Skip to main content
Swing Capital

Neuland Laboratories Ltd

NSE: NEULANDLAB BSE: 524558

Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.[1]

₹16,341
52W: ₹11011 — ₹19748
PE 57.7 · Book ₹1454 · +1024% vs book
Market Cap₹20,965 Cr
Stock P/E57.7Price to Earnings
ROCE26.6%Return on Capital
ROE21.5%Return on Equity
Div. Yield0.07%Face Value ₹10

Strengths

  • +Company is expected to give good quarter
  • +Company has delivered good profit growth of 38.8% CAGR over last 5 years

Weaknesses

  • −Stock is trading at 11.3 times its book value
  • −Promoter holding has decreased over last 3 years: -3.50%

Shareholding Pattern

Promoters32.63%
FIIs20.46%
DIIs15.84%
Public31.08%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters32.72%32.64%▼0.132.68%▲0.032.67%▼0.032.67%32.64%▼0.032.63%▼0.032.63%
FIIs25.72%26.46%▲0.723.86%▼2.622.12%▼1.721.69%▼0.420.6%▼1.120.9%▲0.320.46%▼0.4
DIIs6.39%6.38%▼0.09.09%▲2.710.97%▲1.911.57%▲0.613.55%▲2.014.72%▲1.215.84%▲1.1
Public34.77%34.12%▼0.733.96%▼0.233.85%▼0.133.67%▼0.232.8%▼0.931.76%▼1.031.08%▼0.7

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales393385440311398328293514440776
Expenses272278316250312278258359363469
Operating Profit1211071246186513415577307
OPM %31%28%28%20%22%15%12%30%18%40%
Net Profit8168983210128149640213
EPS ₹62.952.776.6524.9179.0321.6110.6975.1831.5165.64

AI Insights

Revenue Trend

Mar 2026 revenue at ₹2,023Cr, up 37% YoY. OPM at 28%.

Debt Position

Borrowings at ₹301Cr. Debt-to-equity ratio: 0.16x. Healthy balance sheet.

Capex Cycle

CWIP at ₹210Cr (18% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 15.84% (+9.08pp change). FIIs: 20.46% (+0.27pp change). Promoters hold 32.63%.

Margin & Efficiency

ROCE improving from 16% (Mar 2015) to 27% (Mar 2026). Working capital days: 74.

Valuation

PE 57.7x with 26.6% ROCE. Price is 1024% above book value of ₹1,454. Dividend yield: 0.07%.

Recent Announcements